Ontology highlight
ABSTRACT: Background
Purinergic P2Y1 and P2Y12 receptors (P2Y1-R and P2Y12-R) are G protein-coupled receptors (GPCR) activated by adenosine diphosphate (ADP) to mediate platelet activation, thereby playing a pivotal role in hemostasis and thrombosis. While P2Y12-R is the major target of antiplatelet drugs, no P2Y1-R antagonist has yet been developed for clinical use. However, accumulating data suggest that P2Y1-R inhibition would ensure efficient platelet inhibition with minimal effects on bleeding. In this context, an accurate characterization of P2Y1-R antagonists constitutes an important preliminary step.Results
Here, we investigated the pharmacology of P2Y1-R signaling through Gq an
SUBMITTER: Ribes A
PROVIDER: S-EPMC9890698 | biostudies-literature | 2023 Feb
REPOSITORIES: biostudies-literature